149 related articles for article (PubMed ID: 6487472)
1. Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol.
Kendall MJ; Jack DB; Laugher SJ; Lobo J; Rolf Smith S
Br J Clin Pharmacol; 1984 Sep; 18(3):331-5. PubMed ID: 6487472
[TBL] [Abstract][Full Text] [Related]
2. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
[TBL] [Abstract][Full Text] [Related]
3. Interaction between the beta-adrenoceptor blockers metoprolol and atenolol with amitriptyline and their effects on oxidative liver metabolism.
Kirch W; Spahn H; Kitteringham NR; Hutt HJ; Mutschler E; Ohnhaus EE
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):65S-68S. PubMed ID: 6743476
[TBL] [Abstract][Full Text] [Related]
4. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
[TBL] [Abstract][Full Text] [Related]
5. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.
Houtzagers JJ; Streurman O; Regårdh CG
Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199
[TBL] [Abstract][Full Text] [Related]
6. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations.
Eriksson M; Nyberg G; Lidman K; Olofsson B; Bergstrand R
Blood Press Suppl; 1993; 1():16-21. PubMed ID: 7909705
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of atenolol and metoprolol administered together with piroxicam.
Spahn H; Langguth P; Krauss D; Kirch W; Mutschler E
Arch Pharm (Weinheim); 1987 Feb; 320(2):103-7. PubMed ID: 3579517
[No Abstract] [Full Text] [Related]
8. Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
Tateishi T; Nakashima H; Shitou T; Kumagai Y; Ohashi K; Hosoda S; Ebihara A
Eur J Clin Pharmacol; 1989; 36(1):67-70. PubMed ID: 2917591
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
Warrington SJ; Holt D; Johnston A; Fitzsimons TJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):37S-44S. PubMed ID: 6146339
[TBL] [Abstract][Full Text] [Related]
10. The effect of cimetidine on the relative cardioselectivity of atenolol and metoprolol in asthmatic patients.
Ellis ME; Hussain M; Webb AK; Barker NP; Fitzsimons TJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):59S-64S. PubMed ID: 6743475
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol.
Spahn H; Kirch W; Mutschler E; Ohnhaus EE; Kitteringham NR; Lögering HJ; Paar D
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):97S-102S. PubMed ID: 6743480
[TBL] [Abstract][Full Text] [Related]
12. CNS-related subjective symptoms during treatment with beta 1-adrenoceptor antagonists (atenolol, metoprolol): two double-blind placebo controlled studies.
Dimenäs E; Dahlöf C; Olofsson B; Wiklund I
Br J Clin Pharmacol; 1989 Nov; 28(5):527-34. PubMed ID: 2574052
[TBL] [Abstract][Full Text] [Related]
13. Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers.
Weber C; Tam YK; Schmidtke-Schrezenmeier G; Jonkmann JH; van Brummelen P
Eur J Clin Pharmacol; 1996; 51(1):87-90. PubMed ID: 8880057
[TBL] [Abstract][Full Text] [Related]
14. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
[TBL] [Abstract][Full Text] [Related]
15. Interindividual variation of beta-adrenoceptor blocking drugs, plasma concentration and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol.
Dayer P; Leemann T; Marmy A; Rosenthaler J
Eur J Clin Pharmacol; 1985; 28(2):149-53. PubMed ID: 2859203
[TBL] [Abstract][Full Text] [Related]
16. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
Lemmer B; Winkler H; Ohm T; Fink M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
[TBL] [Abstract][Full Text] [Related]
17. Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteers.
Rosenkranz B; Ledermann H; Frölich JC
J Cardiovasc Pharmacol; 1986; 8(5):943-9. PubMed ID: 2429095
[TBL] [Abstract][Full Text] [Related]
18. Variability in the pharmacokinetics of atenolol and metoprolol.
Ledermann H; Bippi H; Boekens H; Frölich JC; Herrmann H; Schmitt-Landherr K
Arzneimittelforschung; 1985; 35(5):848-51. PubMed ID: 4026908
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of metoprolol and its metabolites in dialysis patients.
Seiler KU; Schuster KJ; Meyer GJ; Niedermayer W; Wassermann O
Clin Pharmacokinet; 1980; 5(2):192-8. PubMed ID: 7363534
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
Rigby JW; Scott AK; Hawksworth GM; Petrie JC
Br J Clin Pharmacol; 1985 Oct; 20(4):327-31. PubMed ID: 2866783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
